Ani Pharmaceuticals reported $144.21M in Trade Debtors for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Debtors Change
Ani Pharmaceuticals ANIP:US USD 144.21M 8.21M
Aurora Cannabis Inc ACB:CN CAD 45.94M 1.11M
Canopy Growth Corp WEED:CN CAD 108.24M 11.61M
Depomed DEPO:US USD 44.68M 3.86M
Eli Lilly And LLY:US USD 8.32B 652.4M
Emergent Biosolutions EBS:US USD 191.3M 16.3M
Endo International Ordinary Shares ENDP:US USD 425.95M 75.15M
Heron Therapeutics HRTX:US USD 42.19M 1.88M
Hikma Pharmaceutical HIK:LN USD 893M 82M
Knight Therapeutics Inc GUD:CN CAD 93.59M 1.58M
Lannett LCI:US USD 74.43M 18.6M
Nektar Therapeutics NKTR:US USD 11.53M 1.53M
Novartis NVS:US USD 8.68B 230M
Omeros OMER:US USD 61.6M 3.32M
Perrigo Ordinary Shares PRGO:US USD 739.5M 37.6M
Teva Pharmaceutical TEVA:IT USD 3.73B 741M
Teva Pharmaceutical Industries TEVA:US USD 3.73B 741M